Atyr Pharma Inc (ATYR)

Jun 05, 2025

Atyr PHARMA (NASDAQ:ATYR) Receives Buy Rating from HC Wainwright - Defense World

Jun 05, 2025

Jun 04, 2025

aTyr Pharma reports positive interim results for SSc-ILD treatment By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 04, 2025

aTyr Pharma Announces Findings from Interim Analysis of - GlobeNewswire

Jun 04, 2025

Jun 04, 2025

ATYR Stock Update: HC Wainwright Reiterates 'Buy' Rating with $3 - GuruFocus

Jun 04, 2025

Jun 04, 2025

ATYR Stock Update: HC Wainwright Reiterates 'Buy' Rating with $35 Price Target | ATYR Stock News - GuruFocus

Jun 04, 2025

Jun 04, 2025

aTyr Pharma reports positive interim results for SSc-ILD treatment - Investing.com

Jun 04, 2025

Jun 04, 2025

aTyr Pharma (ATYR) Reports Promising Interim Results for Efzofitimod | ATYR Stock News - GuruFocus

Jun 04, 2025

Jun 04, 2025

aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) - Yahoo Finance

Jun 04, 2025

Jun 04, 2025

Millennium Management LLC Takes $1.33 Million Position in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

Jun 04, 2025

Jun 02, 2025

aTyr Pharma (ATYR) Scheduled for Key Presentation in New York | - GuruFocus

Jun 02, 2025

Jun 02, 2025

aTyr Pharma (ATYR) Scheduled for Key Presentation in New York | ATYR Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

aTyr Pharma stock soars to 52-week high of $4.66 By Investing.com - Investing.com Nigeria

Jun 02, 2025

May 31, 2025

182,625 Shares in Atyr PHARMA INC (NASDAQ:ATYR) Bought by Northern Trust Corp - Defense World

May 31, 2025

May 29, 2025

Atyr PHARMA INC (NASDAQ:ATYR) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

May 29, 2025

May 27, 2025

High Growth Tech Stocks in the US to Watch This May 2025 - Yahoo Finance

May 27, 2025

May 26, 2025

Group One Trading LLC Takes $26,000 Position in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 26, 2025

May 26, 2025

Jane Street Group LLC Invests $720,000 in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 26, 2025

May 24, 2025

aTyr Pharma’s SWOT analysis: biotech firm’s stock poised for potential breakthrough - Investing.com India

May 24, 2025

May 24, 2025

aTyr Pharma’s SWOT analysis: biotech firm’s stock poised for potential breakthrough By Investing.com - Investing.com South Africa

May 24, 2025

May 21, 2025

aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential - Insider Monkey

May 21, 2025

May 20, 2025

aTyr Pharma to Present at Upcoming Investor Conferences - GlobeNewswire

May 20, 2025

May 20, 2025

aTyr Pharma Announces Triple Conference Schedule: RBC, Jefferies, and Piper Sandler Healthcare Events Coming Up - Stock Titan

May 20, 2025

May 20, 2025

13 Best Multibagger Stocks to Invest in Now - Insider Monkey

May 20, 2025

May 19, 2025

aTyr Pharma (ATYR) Highlights Efzofitimod Research at ATS 2025 | ATYR Stock News - GuruFocus

May 19, 2025

May 19, 2025

aTyr Pharma (ATYR) Highlights Efzofitimod Research at ATS 2025 | - GuruFocus

May 19, 2025

May 19, 2025

aTyr Pharma (ATYR) Receives Steady 'Buy' Rating from HC Wainwright | ATYR Stock News - GuruFocus

May 19, 2025

May 19, 2025

Such Is The Power Of Atyr Pharma Inc (NASDAQ: ATYR) - Stocksregister

May 19, 2025

May 19, 2025

aTyr Pharma Presents Three Posters on Efzofitimod at the - GlobeNewswire

May 19, 2025

May 19, 2025

Breakthrough Phase 3 Trial Reveals 158,900 Patients Could Benefit from New Sarcoidosis Treatment - Stock Titan

May 19, 2025

May 19, 2025

Balyasny Asset Management L.P. Buys Shares of 44,310 Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 19, 2025

May 17, 2025

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rul - GuruFocus

May 17, 2025

May 16, 2025

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 16, 2025

May 16, 2025

ATyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025

May 16, 2025

aTyr Pharma Awards 36,200 Shares in Stock Options Under Nasdaq Rule 5635Key Details Revealed - Stock Titan

May 16, 2025

May 16, 2025

Dimensional Fund Advisors LP Makes New $881,000 Investment in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 16, 2025

May 15, 2025

Atyr begins IND-enabling studies with candidate for pulmonary fibrosis - BioWorld MedTech

May 15, 2025

May 15, 2025

10,694 Shares in Atyr PHARMA INC (NASDAQ:ATYR) Acquired by Raymond James Financial Inc. - Defense World

May 15, 2025

May 14, 2025

aTyr Pharma advances new fibrosis treatment candidate By Investing.com - Investing.com South Africa

May 14, 2025

May 14, 2025

ATyr Pharma Plans Investigational New Drug Filing for ATYR0101 in Pulmonary Fibrosis - marketscreener.com

May 14, 2025

May 14, 2025

aTyr Pharma (ATYR) to Present ATYR0101 at 2025 ATS Summit | ATYR Stock News - GuruFocus

May 14, 2025

May 14, 2025

aTyr Pharma advances new fibrosis treatment candidate - Investing.com

May 14, 2025

May 14, 2025

aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis - GlobeNewswire

May 14, 2025

May 14, 2025

Revolutionary Fibrosis-Reversing Drug ATYR0101 Shows Promise in Targeting Deadly Lung Disease - Stock Titan

May 14, 2025

May 14, 2025

Schonfeld Strategic Advisors LLC Takes Position in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 14, 2025

May 12, 2025

Q3 Earnings Forecast for Atyr PHARMA Issued By HC Wainwright - Defense World

May 12, 2025

May 12, 2025

Leerink Partnrs Estimates Atyr PHARMA Q2 Earnings - Defense World

May 12, 2025

May 09, 2025

Is aTyr Pharma, Inc. (ATYR) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey

May 09, 2025

May 09, 2025

Barclays PLC Acquires New Position in Atyr PHARMA INC (NASDAQ:ATYR) - Defense World

May 09, 2025

May 09, 2025

10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey

May 09, 2025

May 08, 2025

Pulmonary Sarcoidosis Market to Reach New Heights in Growth - openPR.com

May 08, 2025